Revvity, Inc. (RVTY) stock analysis
In our weekly check, Revvity, Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 7.
About Revvity, Inc.
Revvity, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NYSE as RVTY.
What our checks show for RVTY
Red flags
- The net margin fell by 16 points over 5 years, to 8.6%: the company keeps less of each sale as profit.
- The gross margin fell by 6.5 points, to 53.1%: costs are rising faster than prices.
- Revenue fell 3.9% a year over the last 3 years.
- The price is 68.3 times earnings (P/E): the market already pays for a lot of future growth.
- The stock has fallen as much as 63% from a peak. Would you have held through that?
- Recovering from its deepest fall took about 3.4 years.
- Return on capital (ROCE) is only 3.4%.
Warning signs
- Analysts expect only about 3.7% a year of growth in revenue.
- Earnings per share fell 20.6% a year over the last 3 years.
- Net profit fell 23.7% a year over the last 3 years.
- The net margin is only 8.6%: little room if costs rise.
- The price swings a lot: 39.7% annual volatility. Expect large ups and downs.
Strengths
- Operating cash flow is 2.59x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 60.9% a year over the next years.
- Analysts expect the net margin to improve by 14.3 points from today's 8.6%.
- Free cash flow is 20.1% of revenue: cash for dividends, buybacks or growth.
- The dividend takes 12% of profit: there is a cushion.
- A large company: market value $17.24 billion.
Next earnings report: 2027-02-01
Similar companies
MEDP · CRL · ICLR · GH · DGX · QGEN
Questions
What grade does Revvity, Inc. (RVTY) have?
In our weekly check, Revvity, Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 7. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of RVTY stock?
This week's biggest flags for Revvity, Inc.: Margins falling, Gross margin falling, Weak revenue growth. In total 12 of 25 checks show a warning or a red flag.
What does Revvity, Inc. do?
Revvity, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NYSE as RVTY.
When does Revvity, Inc. report earnings next?
The next earnings report is expected on 2027-02-01. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis